Home / Home / Resources / Research Summaries / Optimizing Shockwave Therapy for Erectile Dysfunction: The Role of Maintenance Protocols

Optimizing Shockwave Therapy for Erectile Dysfunction: The Role of Maintenance Protocols

Establishing Best Practices for Acoustic Wave Interventions

As the scope of physiotherapy extends robustly into men’s pelvic health, low-intensity extracorporeal shockwave therapy (Li-ESWT) has emerged as a promising non-invasive adjunct for managing organic erectile dysfunction (ED). Originally adopted for musculoskeletal conditions, shockwave therapy is now utilized for its potential to stimulate angiogenesis and improve local hemodynamics in penile tissue. However, one of the primary challenges clinicians face is the absence of a universally standardized dosing protocol. A recently published multicenter, open-label randomized clinical trial sought to determine whether extending treatment with a monthly maintenance phase could yield superior clinical outcomes compared to a traditional weekly protocol alone.

Trial Design: Comparing Standard and Extended Dosing

The study involved 186 men diagnosed with organic erectile dysfunction who were not currently utilizing pharmacological treatments. Designed to provide high-quality evidence, the researchers divided the participants into two groups of 93 men. The first group underwent a standard protocol consisting of six weekly sessions of shockwave therapy. The second group received the same initial six weekly sessions but was additionally prescribed five monthly maintenance sessions. The primary measures of success included the International Index of Erectile Function-Erectile Function domain (IIEF-EF) score, achievement of the minimal clinically important difference (MCID), Erection Hardness Score, and overall self-esteem metrics, tracking the patients up to 24 weeks.

Analyzing the Clinical Impact of Maintenance Therapy

Interestingly, the trial revealed nuanced results regarding raw statistical data versus patient-centered clinical milestones. When looking strictly at the median IIEF-EF scores, both groups showed improvement, but the differences between the maintenance protocol and the weekly-only protocol were not statistically significant at the 12-week and 24-week follow-up marks. However, a deeper dive into the minimal clinically important difference (MCID) painted a significantly different picture. By the 24-week follow-up, an impressive 62.8% of the patients in the maintenance protocol group achieved the MCID, compared to only 35.8% in the weekly protocol group. This adjusted p-value of 0.02 strongly suggests that while median score shifts might appear statistically subtle, the real-world, noticeable improvement for individual patients is vastly enhanced by maintenance dosing. Furthermore, no serious adverse events were reported in either cohort, reaffirming the excellent safety profile of Li-ESWT.

Clinical Implications for Pelvic Health Physiotherapists

For rehabilitation professionals and specialists treating men’s pelvic health, these findings offer vital guidance for protocol design. Relying solely on a short-term, weekly cluster of treatments may leave a substantial portion of patients without clinically meaningful improvement. By integrating just five additional monthly maintenance sessions, clinicians can nearly double the likelihood of their patients reaching a clinically significant breakthrough without increasing the risk of adverse events. While future studies incorporating penile Doppler ultrasound for vascular assessment will be beneficial, the current evidence robustly supports a maintenance-based framework to optimize long-term patient satisfaction and functional outcomes in the treatment of organic erectile dysfunction.

References

Sandoval-Salinas, C., Martinez, J. M., Corredor, H. A., Barba, J., & Patrón, F. (2026). Effectiveness of monthly maintenance low-intensity shockwave therapy added to a weekly protocol for erectile dysfunction: multicenter open-label randomized study. The journal of sexual medicine. https://pubmed.ncbi.nlm.nih.gov/41894472/

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *

WP Twitter Auto Publish Powered By : XYZScripts.com